The Miami Entrepreneur

Dow Jones Newswires: GSK Phase 3 trial for Jemperli endometrial cancer treatment met primary endpoint

Read Time:5 Second

The trial showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Rolls-Royce uses hydrogen produced with wind and tidal power to test jet engine
Next post Chester by-election: Labour hold seat in Rishi Sunak’s first electoral test